Home > Healthcare > Medical Devices > Diagnostic Devices > Endomyocardial Biopsy Market

Endomyocardial Biopsy Market Size

Report ID: GMI6455
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Endomyocardial Biopsy Market size

Endomyocardial Biopsy Market size was valued at USD 321.5 million in 2022 and is estimated to account for USD 619.2 million by 2032. An endomyocardial biopsy is a medical procedure used to obtain a small sample of tissue from the inner lining of the heart, known as the endocardium.

To get key market trends

Download Free Sample

This procedure is typically performed to diagnose and monitor certain heart conditions, especially those that involve inflammation, infection, rejection after heart transplantation, or other disorders that affect the heart muscle or its lining. Technological advancements in medical imaging, catheterization techniques, and biopsy tools can enhance the accuracy, safety, and efficiency of endomyocardial biopsies.

Endomyocardial Biopsy Market Report Attributes
Report Attribute	Details
Base Year:	2022
Endomyocardial Biopsy Market Size in 2022:	USD 321.5 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	6.8%
2032 Value Projection:	USD 619.2 Million
Historical Data for:	2018 to 2022
No. of Pages:	235
Tables, Charts & Figures:	341
Segments covered:	Product, Tip, End-use, and Region
Growth Drivers:	Growing prevalence of cardiovascular diseases Advancements in biopsy techniques and devices Increasing number of heart transplants globally Growing adoption of minimally invasive procedures
Pitfalls & Challenges:	Complications associated with endomyocardial biopsy

Learn more about the key segments shaping this market

Download Free Sample

The growing prevalence of cardiovascular diseases is a major driving factor for the industry. Cardiovascular diseases, such as heart failure, cardiomyopathies, and myocarditis, continue to be a significant global health concern. For instance, as per the World Health Organization (WHO), cardiac diseases are the number one cause of death globally, accounting for an estimated 20.5 million deaths in 2021. Further, the incidence of cardiovascular diseases is increasing, partially due to factors such as sedentary lifestyle, unhealthy diet, tobacco use, obesity, and an increasing aging population base.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market value for endomyocardial biopsy was USD 321.5 million in 2022 and is estimated to account for USD 619.2 million by 2032.

The hospital segment accounted for over 51% share in industry in 2022 and is anticipated to witness significant growth through 2032 as hospitals with active heart transplant programs require regular and thorough monitoring of transplant recipients to detect early signs of rejection.

U.S. market accounted for USD 109 million in 2022 and will witness substantial growth through 2032 attributable to the presence of highly advanced & well-established healthcare infrastructure with specialized cardiac centers and cutting-edge medical technologies.

Argon Medica Devices, Inc, Cordis, Mermaid Medical, Terumo Corporation, Scholten Surgical Instruments, Inc., Changzhou Lookmed Medical Instrument Co., Ltd., Medtronic plc, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical LLC and Merit Medical Systems, Inc. among others.